scholarly journals Strategiczny model funkcjonalny z koordynującą rolą Regionalnego Centrum Oceny Inwestycji wspartego przez Narodowy Fundusz Zdrowia oraz Agencję Oceny Technologii Medycznych i Taryfikacji – model mieszany

2021 ◽  
Vol 18 (4) ◽  
pp. 298-309
Author(s):  
Małgorzata Gałązka-Sobotka ◽  
Iwona Kowalska-Bobko
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Medical Technology ◽  
Public Funding ◽  
Functional Model ◽  
Health Technology ◽  
Mixed System ◽  
Medical Technologies ◽  
Hospital Units ◽  
Tariff System

Mixed functional model HB-HTA with the coordinating role of the Regional Center for Investments supported by the Polish National Fund and Agency for Health Technology Assessment and Tariff System The implementation of the strategic model for hospital health technology assessment in Poland requires the involvement of many stakeholders. HB-HTA fundamentally concerns hospitals and how they rationalize decision making in implementing innovative medical technologies. However, the need to obtain public funding after verifying the effectiveness of a given medical technology or to keep up with the evolving HB-HTA method­ology naturally requires the involvement of both the payer (NFZ) and the Agency for Health Technology Assessment and Tariff System in activities connected with the implementation and development of HB-HTA. An important aspect of the coordination of activities in relation to hospital HTA is also the support given to hospitals by regional authorities – competent health departments in voivodeship offices – by assessing HB-HTA reports prepared by the hospitals and indicating regional competitive potential of a given medical technology. This creates a hybrid/mixed system of insti­tutional support for innovative medical technologies implemented in hospitals. This institutional plurality within HB-HTA is a clear asset, strengthening the hospital’s planned undertaking substantively and financially, especially when the assistance mechanisms undertaken are flexible, soft in nature, and allow hospital units to shape effective HB-HTA activities.

scholarly journals Identyfikacja kluczowych podmiotów i ich ról oraz możliwości i barier dla wdrożenia koordynacji regionalnej procesu HB-HTA w Polsce

2021 ◽  
Vol 18 (4) ◽  
pp. 247-258
Author(s):  
Małgorzata Gałązka-Sobotka ◽  
Maciej Furman ◽  
Iwona Kowalska-Bobko
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Functional Model ◽  
Hospital Management ◽  
Health Technology ◽  
Hospital Treatment ◽  
Final Decision ◽  
Medical Technologies ◽  
Hospital Units ◽  
Regional Authorities

Identification of key actors involved in the implementation of a regional functional model for hospital evaluation The concept of Hospital-Based Health Technology Assessment (HB-HTA) is conducive to the rationalization of decisions made by the hospital management regarding the implementation of innovative medical technologies in hospital units. This type of HTA is a bottom-up hospital initiative, but usually it is also supported systemically and involves other entities, such as: the Agency for Health Technology Assessment and Tariff System, the payer, or regional authorities. Providing support to the hospital in making the final decision on the implementation of innovative medical technology may include such aspects as: obtaining necessary funding for the implementation of technology, identification of the competitive potential of the planned project, or following the HB-HTA methodology in reporting. The process of decentralization of hospital management in Poland induces scholars to carry out research and draw conclusions about the involvement of regional authorities, mainly voivodeship offices and their departments responsible for health issues, in the HB-HTA process. The primary objectives of this paper are to present the results of research and analysis of the development and popularization of HB-HTA in Poland. These will be discussed in relation to the implementation of a regional functional model for hospital evaluation of innovative medical technologies and the creation of rules of cooperation between important institutions of sectoral (health) policy to support and develop HB-HTA at the regional (voivodeship) level, as well as the dissemination of knowledge, popularization of HB-HTA, and promotion of good practices. Słowa kluczowe: HB-HTA, lecznictwo szpitalne, ocena technologii medycznych, szpital, szpitalna ocena technologii medycznych, technologia medyczna, zarządzanie ochroną zdrowia, health care management, health technology assessment, Hospital-Based Health Technology Assessment, health technology, hospital, hospital treatment

scholarly journals Health Technology Assessment System in Sweden

2019 ◽  
pp. 16-23
Author(s):  
Vitaly Vladimirovich Omelyanovskiy ◽  
Filipp Vasilievich Gorkavenko ◽  
Yegor Sergeevich Saybel ◽  
Georgii Rubenovich Khachatryan
Keyword(s):  
Health Technology Assessment ◽  
Social Services ◽  
Technology Assessment ◽  
Medical Technology ◽  
Health Technology ◽  
Assessment System ◽  
Reimbursement System ◽  
Medical Technologies ◽  
The World ◽  
Regulatory Functions

Sweden is one of the first countries who establish health technology assessment (HTA) agency. Nowadays, there are two HTA organizations in the country. The first is one of the oldest in the world – the Swedish agency for health technology assessment and assessment of social services (SBU), and the second is the Council The Dental and Pharmaceutical Benefits Agency (TLV). Having similar tasks, organizations are created for different purposes. TLV assesses medical technologies within state reimbursement system, its purpose is to ensure the efficient use of budget funds. The SBU does not participate in the reimbursement system and does not have any regulatory functions, its purpose is to respond to public inquiries regarding the use of any medical technology. Agencies differ in the number of annually published reports, their types and objects of evaluation. Wherein the work of both institutions is characterized by a wide involvement of independent experts, outside organizations and particular attention to the economic component of the assessment.

PP206 Health Technology Assessment Guidance In The United Kingdom: Addressing Issues Specific To Medical Devices

2021 ◽  
Vol 37 (S1) ◽  
pp. 26-26
Author(s):  
Scott Gibson ◽  
Sita Saunders ◽  
Amanda Hansson Hedblom ◽  
Maximilian Blüher ◽  
Rafael Torrejon Torres ◽  
...  
Keyword(s):  
United Kingdom ◽  
Health Technology Assessment ◽  
Medical Devices ◽  
Technology Assessment ◽  
Healthcare Providers ◽  
Economic Assessment ◽  
Health Technology ◽  
Training Costs ◽  
Medical Technologies ◽  
The United Kingdom

IntroductionThe United Kingdom spends approximately GBP4.2 billion (USD5.6 billion; EUR4.7 billion) each year on medical devices, but healthcare providers receive little health technology assessment (HTA) guidance on cost-effective device procurement. Our objective was to assess the availability of HTA guidance for medical technologies and to identify key challenges related to the economic assessment of these technologies.MethodsNational Institute for Health and Care Excellence technology appraisal (TA) and Medical Technologies Evaluation Programme (MTEP) appraisals published online between November 2009 and October 2020 were identified. The “case for adoption” recommendation, type of devices, and critiques of economic analyses for each MTEP appraisal were extracted and categorized.ResultsIn comparison to 415 publicly available TAs for pharmaceuticals, only 45 medical technologies have been appraised through the MTEP. MTEP-submitted technologies can be categorized into diagnostic (7), monitoring (3), prophylaxis (5), therapeutic (28), and other (2). Furthermore, 11 were implants, seven were used by patients, and 27 had provider interaction. Major points of MTEP criticism were a failure to model cost consequences, training costs, and organizational impact. There was also the barrier of transferring costs across budgeting divisions.ConclusionsIn comparison to HTA guidance for pharmaceuticals, there is a dearth of medical device guidance. Therapeutic and implantable devices appear to be disproportionately overrepresented in the MTEP process. This may be because their appraisal is most akin to pharmaceuticals, for which HTA processes are well established. To encourage more HTAs of medical devices, HTA guidance should elaborate on issues specifically related to medical devices.

Ethical perspectives on health technology assessment

2004 ◽  
Vol 20 (1) ◽  
pp. 71-76 ◽  
Author(s):  
Henk ten Have
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Medical Technology ◽  
Health Technology ◽  
Minor Role ◽  
Engineering Model ◽  
Ethical Aspects ◽  
A Value ◽  
Definition Of ◽  
A Minor

This study analyses why ethical aspects play a minor role in health technology assessment (HTA) studies, even when comprehensive approaches of technology assessment are advocated. Technology is often regarded as a value-neutral tool. At the same time, bioethics is dominated by an engineering model. Ethical contributions to evaluation of medical technology should go beyond issues of application in clinical practice and focus also on the definition of problems, the demarcation of technical and nontechnical issues, and the morally problematic implications of technologies.

scholarly journals Different methods for ethical analysis in health technology assessment: An empirical study

2011 ◽  
Vol 27 (4) ◽  
pp. 305-312 ◽  
Author(s):  
Samuli I. Saarni ◽  
Annette Braunack-Mayer ◽  
Bjørn Hofmann ◽  
Gert Jan van der Wilt
Keyword(s):  
Empirical Study ◽  
Health Technology Assessment ◽  
Obesity Surgery ◽  
Technology Assessment ◽  
Ethical Issues ◽  
Personal Responsibility ◽  
Public Funding ◽  
Stakeholder Involvement ◽  
Health Technology ◽  
Ethical Analysis

Objectives: Ethical analysis can highlight important ethical issues related to implementing a technology, values inherent in the technology itself, and value-decisions underlying the health technology assessment (HTA) process. Ethical analysis is a well-acknowledged part of HTA, yet seldom included in practice. One reason for this is lack of knowledge about the properties and differences between the methods available. This study compares different methods for ethical analysis within HTA.Methods: Ethical issues related to bariatric (obesity) surgery were independently evaluated using axiological, casuist, principlist, and EUnetHTA models for ethical analysis within HTA. The methods and results are presented and compared.Results: Despite varying theoretical underpinnings and practical approaches, the four methods identified similar themes: personal responsibility, self-infliction, discrimination, justice, public funding, and stakeholder involvement. The axiological and EUnetHTA models identified a wider range of arguments, whereas casuistry and principlism concentrated more on analyzing a narrower set of arguments deemed more important.Conclusions: Different methods can be successfully used for conducting ethical analysis within HTA. Although our study does not show that different methods in ethics always produce similar results, it supports the view that different methods of ethics can yield relevantly similar results. This suggests that the key conclusions of ethical analyses within HTA can be transferable between methods and countries. The systematic and transparent use of some method of ethics appears more important than the choice of the exact method.

scholarly journals A review of implementation frameworks to operationalize health technology assessment recommendations for medical technologies in the Singapore setting

2021 ◽  
Vol 37 (1) ◽  
Author(s):  
Vidhya Segar ◽  
Priscilla Kailian Ang ◽  
Chris Foteff ◽  
Kwong Ng
Keyword(s):  
Health Technology Assessment ◽  
Healthcare System ◽  
Technology Assessment ◽  
Organizational Support ◽  
Information Dissemination ◽  
Health Technology ◽  
Flow Diagram ◽  
Dissemination And Implementation ◽  
Implementation Framework ◽  
Medical Technologies

Abstract Background Methodologies of health technology assessment (HTA) for medical technologies are well established; yet, operational frameworks that enable appropriate uptake of HTA recommendations into routine clinical practice are lacking. This review aims to identify the key themes needed to guide the planning and implementation of HTA subsidy decisions for medical technologies such as diagnostics, medical devices, and services and to monitor their impact on a complex multipayer healthcare system like Singapore. Methods A literature search of implementation frameworks was conducted up to 20 December 2020 and was documented in a flow diagram. A thematic analysis of the evidence base was performed using the Braun and Clark approach to identify key themes, from which an implementation framework suitable for Singapore's healthcare system could be developed. Results The searches yielded forty-four articles for review, from which twenty themes were identified. The top ten themes constituted the key themes of implementation essential for local adaptation and were categorized into five domains: implementation strategy, organizational support, stakeholder engagement, information dissemination, and implementation outcomes and evaluation. These domains provide operational guidance to methodically identify gaps to facilitate sustainable implementation of HTA-informed medical technology subsidy decisions. Conclusion A robust and adaptable implementation of HTA-informed subsidy decisions is crucial to optimize its intended impact of improving patient outcomes per dollar spent. The key themes of an implementation framework should capture the important aspects of organizational feasibility to ensure successful adoption in a complex multipayer healthcare system like Singapore.

SHARING AND COLLECTING HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT REPORTS INTERNATIONALLY: IS AN EXTENSIVE PARTICIPATION OF STAKEHOLDERS REALISTIC?

2018 ◽  
Vol 34 (5) ◽  
pp. 527-534 ◽  
Author(s):  
Joost Verbeek ◽  
Mickaël Hiligsmann ◽  
Americo Cicchetti ◽  
Marco Marchetti
Keyword(s):  
Content Analysis ◽  
Qualitative Study ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Response Rate ◽  
Health Technology ◽  
International Group ◽  
Medical Technologies ◽  
International Scale ◽  
Large Community

Objectives:The emergence of new medical technologies and budget restrictions has led to a substantial increase in the use of hospital-based health technology assessment (HB-HTA). This qualitative study explores whether there is a possibility and interest to realize the collection and dissemination of HB-HTA reports on an international scale by exploring the opinions from HB-HTA experts.Methods:A survey was designed and sent to an international group of experts knowledgeable in HB-HTA from eighteen different countries. The survey contained questions about their opinions on the collection and distribution of HB-HTA information, and about the meaningful dimensions, barriers and values about a database. The data obtained were analyzed through the method of content analysis.Results:A total of thirty-six experts (response rate of 18.3 percent) responded to the survey. The obtained data shows that all respondents agree that the collection of HB-HTA reports is useful. Moreover, 41.7 percent of respondents that are in the position of sharing HB-HTA reports (n= 24) mentioned that full HB-HTA reports can be shared. Many other respondents reported that confidentiality (45.7 percent) and investment into a database (40.0 percent) are important barriers for the dissemination of HB-HTA reports.Conclusions:There seem to be enough demand and willingness to share all or most reports by a large community of HB-HTA producers. Therefore, there is a need for a well-designed database with regular maintenance and complete, comparable, and qualitative HB-HTA reports. The database of the AdHopHTA project could potentially facilitate this process.

scholarly journals On the integration of early health technology assessment in the innovation process: reflections from five stakeholders

2020 ◽  
Vol 36 (5) ◽  
pp. 481-485
Author(s):  
Marcia Tummers ◽  
Kari Kværner ◽  
Laura Sampietro-Colom ◽  
Markus Siebert ◽  
Murray Krahn ◽  
...  
Keyword(s):  
Best Practices ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Medical Technology ◽  
Innovation Process ◽  
Health Technology ◽  
Value Assessment ◽  
Early Assessment ◽  
Early Health Technology Assessment ◽  
Early Health

AbstractEarly health technology assessment (HTA), which includes all methods used to inform industry and other stakeholders about the potential value of new medical products in development, including methods to quantify and manage uncertainty, has seen many applications in recent years. However, it is still unclear how such early value assessments can be integrated into the technology innovation process. This commentary contributes to the discussion on the purposes early HTA can serve. Similarities and differences in the perspectives of five stakeholders (i.e., the hospital, the patient, the assessor, the medical device industry, and the policy maker) on the purpose, value, and potential challenges of early HTA are described. All five stakeholders agreed that integrating early HTA in the innovation process has the possibility to shape and refine an innovation, and inform research and development decisions. The early assessment, using a variety of methodologies, can provide insights that are relevant for all stakeholders but several challenges, for example, feasibility and responsibility, need to be addressed before early HTA can become standard practice. For early evaluations to be successful, all relevant stakeholders including patients need to be involved. Also, nimble, flexible assessment methods are needed that fit the dynamics of medical technology. Best practices should be shared to optimize both the innovation process and the methods to perform an early value assessment.

Sign in / Sign up

Export Citation Format

Share Document